Vor Biopharma Inc. (VOR) — Shareholders' Equity
| Fiscal Year | Shareholders' Equity | Change YoY |
|---|---|---|
| 2025 | -$164.31M | -270.0% |
| 2024 | $96.66M | -35.9% |
| 2023 | $150.72M | -39.9% |
| 2022 | $250.61M | +15.9% |
| 2021 | $216.26M | +466.1% |
| 2020 | -$59.06M | -238.9% |
| 2019 | -$17.43M | — |
| Fiscal Year | Shareholders' Equity | Change YoY |
|---|---|---|
| 2025 | -$164.31M | -270.0% |
| 2024 | $96.66M | -35.9% |
| 2023 | $150.72M | -39.9% |
| 2022 | $250.61M | +15.9% |
| 2021 | $216.26M | +466.1% |
| 2020 | -$59.06M | -238.9% |
| 2019 | -$17.43M | — |